newsfilter
← Latest News
GlobeNewswire·

FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19

ROCKVILLE, Md. and CHESTERBROOK, Pa., May 11, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ:CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases, today announced